← Back to Search

Biomarker

CRP value for Staphylococcal Sepsis

N/A
Waitlist Available
Led By Robert Stenstrom, MD, PhD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 28 days
Awards & highlights
No Placebo-Only Group

Summary

This trial uses a quick test to measure a protein that increases during infections. It targets emergency department patients with sepsis to help doctors decide if further blood tests are needed. The protein increases specifically in the blood of sepsis patients and is useful for identifying and assessing the severity of infection.

Eligible Conditions
  • Staphylococcal Sepsis
  • Catheter-Associated Bacteremia
  • Sepsis
  • Infections
  • Bacterial Blood Infection

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~28 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 28 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Blood culture obtained
Secondary study objectives
28 day mortality
Admission to hospital
Antibiotic prescribing
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CRP valueExperimental Treatment1 Intervention
The patients point of care CRP value is known by the treating physician
Group II: CRP value unknownActive Control1 Intervention
The patients point of care CRP value is not known by the treating physician

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,465 Previous Clinical Trials
2,485,289 Total Patients Enrolled
Providence Health & ServicesOTHER
123 Previous Clinical Trials
823,585 Total Patients Enrolled
Robert Stenstrom, MD, PhDPrincipal InvestigatorProvidence Health & Services
~24 spots leftby Nov 2025